[HTML][HTML] SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates
At the forefront of biopharmaceutical industry, the messenger RNA (mRNA) technology offers
a flexible and scalable platform to address the urgent need for world-wide immunization in …
a flexible and scalable platform to address the urgent need for world-wide immunization in …
Safety and immunogenicity of COReNAPCIN, a SARS-CoV-2 mRNA vaccine, as a fourth heterologous booster in healthy Iranian adults: A double-blind, randomized …
…, R Alimohammadi, N Khajavirad, M Porgoo… - International …, 2024 - Elsevier
The recurrent COVID-19 infection, despite global vaccination, highlights the need for booster
doses. A heterologous booster has been suggested to enhance immunity and protection …
doses. A heterologous booster has been suggested to enhance immunity and protection …
Safety and immunogenicity of COReNAPCIN®, a SARS-CoV-2 mRNA vaccine; a randomized, double-blind, placebo-controlled phase 1 clinical trial
…, S Pouya, R Alimohammadi, N Khajavirad, M Porgoo… - medRxiv, 2023 - medrxiv.org
The repeated COVID-19 outbreaks, despite global vaccination, highlights the need for booster
doses. Here, we present the outcomes, up until day 90 post vaccination, of a randomized, …
doses. Here, we present the outcomes, up until day 90 post vaccination, of a randomized, …
mRNA-based vaccine candidate COReNAPCIN® induces robust humoral and cellular immunity in mice and non-human primates
R Alimohammadi, M Porgoo, M Eftekhary, SH Kiaie… - bioRxiv, 2022 - biorxiv.org
At the forefront of biopharmaceutical industry, the messenger RNA (mRNA) technology offers
a flexible and scalable platform to address the urgent need for world-wide immunization in …
a flexible and scalable platform to address the urgent need for world-wide immunization in …
mRNA-based vaccine candidate COReNAPCIN (R) induces robust humoral and cellular immunity in mice and non-human primates (preprint)
R Alimohammadi, M Porgoo, M Eftekhary, SH Kiaie… - 2022 - pesquisa.bvsalud.org
At the forefront of biopharmaceutical industry, the messenger RNA (mRNA) technology offers
a flexible and scalable platform to address the urgent need for world-wide immunization in …
a flexible and scalable platform to address the urgent need for world-wide immunization in …